Healthcare & Life Sciences
Selecta Biosciences
Selecta Biosciences is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Selecta Biosciences
Selecta Biosciences is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Selecta Biosciences is a clinical-stage biopharmaceutical company developing tolerogenic Synthetic Vaccine Particles (SVP™) intended to mitigate unwanted immune responses and enable non-immunogenic biologic therapies for rare and serious diseases.
Explore Selecta Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.